These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Identifying adherent patients to newly initiated statins using previous adherence to chronic medications. Majd Z, Mohan A, Paranjpe R, Abughosh SM. J Manag Care Spec Pharm; 2021 Feb; 27(2):186-197. PubMed ID: 33506725 [Abstract] [Full Text] [Related]
4. Evaluating Success Factors of a Medication Adherence Tracker Pilot Program in Improving Part D Medication Adherence Metrics in a Medicare Advantage Plan: Importance of Provider Engagement. Hong M, Esse T, Vadhariya A, Gallardo E, Fosshat MA, Mamvou J, Bruce L, Serna O, Abughosh S. J Manag Care Spec Pharm; 2020 May; 26(5):662-667. PubMed ID: 32347173 [Abstract] [Full Text] [Related]
5. Change in Proportion of Days Covered for Statins Following Implementation of a Pharmacy Student Adherence Outreach Program. Tamargo C, Sando K, Prados Y, Cowart K. J Manag Care Spec Pharm; 2019 May; 25(5):588-592. PubMed ID: 31039060 [Abstract] [Full Text] [Related]
6. Antihyperlipidemic Medication Treatment Patterns and Statin Adherence Among Patients with ASCVD in a Managed Care Plan After Release of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol. Bellows BK, Olsen CJ, Voelker J, Wander C. J Manag Care Spec Pharm; 2016 Aug; 22(8):892-900. PubMed ID: 27459651 [Abstract] [Full Text] [Related]
7. A Pharmacist Telephone Intervention to Identify Adherence Barriers and Improve Adherence Among Nonadherent Patients with Comorbid Hypertension and Diabetes in a Medicare Advantage Plan. Abughosh SM, Wang X, Serna O, Henges C, Masilamani S, Essien EJ, Chung N, Fleming M. J Manag Care Spec Pharm; 2016 Jan; 22(1):63-73. PubMed ID: 27015053 [Abstract] [Full Text] [Related]
8. Patterns of Statin Use in a Real-World Population of Patients at High Cardiovascular Risk. Lin I, Sung J, Sanchez RJ, Mallya UG, Friedman M, Panaccio M, Koren A, Neumann P, Menzin J. J Manag Care Spec Pharm; 2016 Jun; 22(6):685-98. PubMed ID: 27231796 [Abstract] [Full Text] [Related]
9. Evaluating trajectories of statin adherence after a motivational interviewing intervention. Paranjpe R, Vadhariya A, Choi J, Essien EJ, Esse TW, Gallardo E, Serna O, Abughosh S. J Am Pharm Assoc (2003); 2020 Jun; 60(6):892-898. PubMed ID: 32680781 [Abstract] [Full Text] [Related]
10. A Motivational Interviewing Intervention to Improve Adherence to ACEIs/ARBs among Nonadherent Older Adults with Comorbid Hypertension and Diabetes. Mohan A, Majd Z, Johnson ML, Essien EJ, Barner J, Serna O, Gallardo E, Fleming ML, Ordonez N, Holstad MM, Abughosh SM. Drugs Aging; 2023 Apr; 40(4):377-390. PubMed ID: 36847995 [Abstract] [Full Text] [Related]
11. Trajectories of adherence to ACEI/ARB medications following a motivational interviewing intervention among Medicare Advantage beneficiaries in Texas. Majd Z, Mohan A, Fatima B, Johnson ML, Essien EJ, Abughosh SM. Patient Educ Couns; 2024 Feb; 119():108073. PubMed ID: 38039785 [Abstract] [Full Text] [Related]
12. Medication Adherence to Antihypertensive Triple-Combination Therapy Among Patients Enrolled in a Medicare Advantage Plan. Wang X, Chen H, Essien E, Wu J, Serna O, Paranjpe R, Abughosh S. J Manag Care Spec Pharm; 2019 Jun; 25(6):678-686. PubMed ID: 31134857 [Abstract] [Full Text] [Related]
13. Patient-reported barriers to statin adherence: Excerpts from a motivational interviewing intervention in older adults. Vadhariya A, Paranjpe R, Essien EJ, Johnson ML, Fleming ML, Esse TW, Gallardo E, Serna O, Choi J, Boklage S, Abughosh SM. J Am Pharm Assoc (2003); 2021 Jun; 61(1):60-67.e1. PubMed ID: 33032947 [Abstract] [Full Text] [Related]
14. Using Previous Medication Adherence to Predict Future Adherence. Kumamaru H, Lee MP, Choudhry NK, Dong YH, Krumme AA, Khan N, Brill G, Kohsaka S, Miyata H, Schneeweiss S, Gagne JJ. J Manag Care Spec Pharm; 2018 Nov; 24(11):1146-1155. PubMed ID: 30362915 [Abstract] [Full Text] [Related]
15. Using group-based trajectory modeling to characterize the association of past ACEIs/ARBs adherence with subsequent statin adherence patterns among new statin users. Majd Z, Mohan A, Abughosh SM. J Am Pharm Assoc (2003); 2021 Nov; 61(6):829-837.e2. PubMed ID: 34344613 [Abstract] [Full Text] [Related]
16. Adherence, Persistence, and Health Care Costs for Patients Receiving Dipeptidyl Peptidase-4 Inhibitors. Rascati KL, Worley K, Meah Y, Everhart D. J Manag Care Spec Pharm; 2017 Mar; 23(3):299-306. PubMed ID: 28230454 [Abstract] [Full Text] [Related]
17. Assessing the association between medication adherence, as defined in quality measures, and disease-state control, health care utilization, and costs in a retrospective database analysis of Medicare supplemental beneficiaries using statin medications. Axon DR, Vaffis S, Chinthammit C, Lott BE, Taylor AM, Pickering M, Black H, Warholak T, Campbell PJ. J Manag Care Spec Pharm; 2020 Dec; 26(12):1529-1537. PubMed ID: 33251989 [Abstract] [Full Text] [Related]
18. Predictors of Nonadherence to Topical Intraocular Pressure Reduction Medications Among Medicare Members: A Claims-Based Retrospective Cohort Study. Sheer R, Bunniran S, Uribe C, Fiscella RG, Patel VD, Chandwani HS. J Manag Care Spec Pharm; 2016 Jul; 22(7):808-817a. PubMed ID: 27348282 [Abstract] [Full Text] [Related]
19. Risk of Nondherence to Diabetes Medications Among Medicare Advantage Enrollees: Development of a Validated Risk Prediction Tool. Mhatre SK, Serna O, Sansgiry S, Fleming ML, Essien EJ, Sansgiry SS. J Manag Care Spec Pharm; 2016 Nov; 22(11):1293-1301. PubMed ID: 27783546 [Abstract] [Full Text] [Related]
20. Evaluating perceptions of social determinants of health and Part D star performance of Medicare Advantage-contracted primary care providers serving a South Texas market. Payne R, Esse T, Qian J, Mohan A, Vadhariya A, Becho-Dominguez G, Serna O, Villarreal K, Abughosh S. J Manag Care Spec Pharm; 2021 May; 27(5):544-553. PubMed ID: 33908279 [Abstract] [Full Text] [Related] Page: [Next] [New Search]